Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Zamaporvint by Redx Pharma for Metastatic Colorectal Cancer: Likelihood of Approval
Zamaporvint is under clinical development by Redx Pharma and currently in Phase II for Metastatic Colorectal Cancer. According to GlobalData,...
Data Insights
Zamaporvint by Redx Pharma for Extrahepatic Bile Duct Cancer: Likelihood of Approval
Zamaporvint is under clinical development by Redx Pharma and currently in Phase II for Extrahepatic Bile Duct Cancer. According to...